Endothelial α1-adrenergic receptor activation improves cardiac function in septic mice via PKC-ERK/p38MAPK signaling pathway
International Immunopharmacology · 2024-11 · 141 · 112937
DOI: 10.1016/j.intimp.2024.112937 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-11. Verfasst von Tian Tian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, School of Medicine, Jinan University, Guangzhou 510632, China. Hauptthemen laut MEDLINE: Sepsis, Receptors, Adrenergic, alpha-1, Protein Kinase C, p38 Mitogen-Activated Protein Kinases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Cardiomyopathy is particularly common in septic patients. Our previous studies have shown that activation of the alpha 1 adrenergic receptor (α1-AR) on cardiomyocytes inhibits sepsis-induced myocardial dysfunction. However, the role of cardiac endothelial α1-AR in septic cardiomyopathy has not been determined. Here, we identified α1-AR expression in mouse and human endothelial cells and showed that activation of α1-AR with phenylephrine (PE) improved cardiac function and survival by preventing cardiac endothelial injury in septic mice. Mechanistically, activating α1-AR with PE decreased the expression of ICAM-1, VCAM-1, iNOS, E-selectin, and p-p38MAPK, while promoting PKC and ERK1/2 phosphorylation in LPS-treated endothelial cells. These effects were abolished by a PKC inhibitor or α1-AR antagonist. PE also reduced p65 nuclear translocation, but this suppression is not blocked by PKC inhibition. Treatment with U0126 (a specific ERK1/2 inhibitor) reversed the effects of PE on p38MAPK phosphorylation. Our results demonstrate that cardiac endothelial α1-AR activation prevents sepsis-induced myocardial dysfunction in mice by inhibiting the endothelial injury via PKC-ERK/p38MAPK signaling pathway and a PKC-independent inhibition of p65 nuclear translocation. These findings offer a new perspective for septic patients with cardiac dysfunction by inhibiting cardiac endothelial cell injury through α1-AR activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, School of Medicine, Jinan University, Guangzhou 510632, China.
- Department of Anesthesiology, The First Affiliated Hospital, Jinan University, Guangzhou 510632, Guangdong, China.
- Department of Pathophysiology, Zhuhai Campus of Zunyi Medical University, Zhuhai 519041, China.
- Department of Pathophysiology, School of Medicine, Jinan University, Guangzhou 510632, China. Electronic address: lihongmei@jnu.edu.cn.
Zitieren
APA
Tian, T., Yu, Q., Yang, D., Zhang, X., Zhang, C., Li, J., Luo, T., Zhang, K., Lv, X., Wang, Y., Wang, H., & Li, H. (2024). Endothelial α1-adrenergic receptor activation improves cardiac function in septic mice via PKC-ERK/p38MAPK signaling pathway. International Immunopharmacology, 141, 112937. https://doi.org/10.1016/j.intimp.2024.112937
Vancouver
Tian T, Yu Q, Yang D, Zhang X, Zhang C, Li J, et al. Endothelial α1-adrenergic receptor activation improves cardiac function in septic mice via PKC-ERK/p38MAPK signaling pathway. International Immunopharmacology. 2024;141:112937. doi:10.1016/j.intimp.2024.112937
BibTeX
@article{Tian2024,
author = {Tian, Tian and Yu, Qing and Yang, Duomeng and Zhang, Xue and Zhang, Chanjuan and Li, Jianling and Luo, Tao and Zhang, Keke and Lv, Xiuxiu and Wang, Yiyang and Wang, Huadong and Li, Hongmei},
title = {Endothelial α1-adrenergic receptor activation improves cardiac function in septic mice via PKC-ERK/p38MAPK signaling pathway},
journal = {International Immunopharmacology},
year = {2024},
volume = {141},
pages = {112937},
doi = {10.1016/j.intimp.2024.112937}
}
EUVIMED